These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21440591)

  • 1. IL28B single nucleotide polymorphisms in the treatment of hepatitis C.
    Lange CM; Zeuzem S
    J Hepatol; 2011 Sep; 55(3):692-701. PubMed ID: 21440591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
    New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
    Grebely J; Petoumenos K; Hellard M; Matthews GV; Suppiah V; Applegate T; Yeung B; Marks P; Rawlinson W; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ;
    Hepatology; 2010 Oct; 52(4):1216-24. PubMed ID: 20803561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.
    Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; García-Álvarez M; Resino S
    BMC Med; 2013 Jan; 11():6. PubMed ID: 23298311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.
    Berger CT; Kim AY
    Infect Dis Clin North Am; 2012 Dec; 26(4):863-77. PubMed ID: 23083820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C.
    Bellanti F; Vendemiale G; Altomare E; Serviddio G
    Clin Dev Immunol; 2012; 2012():849373. PubMed ID: 22966241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
    Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of non-genotype 1 hepatitis C virus patients.
    Mangia A; Mottola L
    Curr Gastroenterol Rep; 2012 Feb; 14(1):87-93. PubMed ID: 22113745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IL28 B and IL10 Polymorphism with HCV Infection and Direct Antiviral Treatment.
    Junaid K; Rasool H; Ul Mustafa A; Ejaz H; Alsrhani A; Yasmeen H; Younas S; Abdalla AE; Abdalla Abosalif KO; Mohamed Hamam SS
    Ann Clin Lab Sci; 2021 Jul; 51(4):512-520. PubMed ID: 34452889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL28B for chronic hepatitis C treatment toward personalized medicine.
    Matsuura K; Watanabe T; Tanaka Y
    J Gastroenterol Hepatol; 2014 Feb; 29(2):241-9. PubMed ID: 24325405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.
    Thomas DL; Thio CL; Martin MP; Qi Y; Ge D; O'Huigin C; Kidd J; Kidd K; Khakoo SI; Alexander G; Goedert JJ; Kirk GD; Donfield SM; Rosen HR; Tobler LH; Busch MP; McHutchison JG; Goldstein DB; Carrington M
    Nature; 2009 Oct; 461(7265):798-801. PubMed ID: 19759533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1.
    Akkız H; Akgöllü E; Bekar A; Yıldırım S; Sandıkçı M; Ülger Y; Yalınbaş Kaya B; Kuran S; Üsküdar O
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):711-7. PubMed ID: 25857516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel.
    Maor Y; Morali G; Bashari D; Pénaranda G; Schapiro JM; Martinowitz U; Halfon P
    Haemophilia; 2013 Jan; 19(1):150-6. PubMed ID: 22913807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.
    Mangia A; Santoro R; Copetti M; Massari M; Piazzolla V; Spada E; Cappucci G; Missale G; Mottola L; Agostinacchio E; Mauro Ld; Zuccaro O; Maio P; Pellegrini F; Folgori A; Ferrari C
    J Hepatol; 2013 Aug; 59(2):221-8. PubMed ID: 23587473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
    Ranjan P; Fletcher GJ; Radhakrishnan M; Sivakumar J; Premkumar PS; Goel A; Zachariah UG; Abraham P
    Indian J Med Microbiol; 2016; 34(3):335-41. PubMed ID: 27514956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The function and application of the IL28B gene in HCV infection and treatment].
    Ma K; Zhang AM; Xia XS
    Yi Chuan; 2013 Nov; 35(11):1244-52. PubMed ID: 24579307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.
    Lotrich FE; Loftis JM; Ferrell RE; Rabinovitz M; Hauser P
    J Interferon Cytokine Res; 2011 Mar; 31(3):331-6. PubMed ID: 21133812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining baseline demographics: the role of genetic testing in hepatitis C virus infection.
    Holmes JA; Desmond PV; Thompson AJ
    Clin Liver Dis; 2011 Aug; 15(3):497-513. PubMed ID: 21867933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.